Inadvertent Sodium Administration from Medicines, Intravenous Fluid Therapy, and Diluents in Patients with Heart Failure with Reduced Ejection Fraction Admitted to Cardiac and Non-Cardiac Units in a Tertiary Hospital Network
Research in Clinical Pharmacy · 2023
DOI: 10.59931/rcp.23.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2023. Verfasst von Mikah Peterson und 2 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BYNC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background: Sodium restriction is an accepted nonpharmacological strategy for fluid management in heart failure.In an intensive care unit (ICU) setting, high sodium loads have been associated with avoidable derailment of fluid balance.The international guidelines recommend restricting the total sodium intake to
Zitieren
APA
Peterson, M., Potts, C., & Ang, R. J. (2023). Inadvertent Sodium Administration from Medicines, Intravenous Fluid Therapy, and Diluents in Patients with Heart Failure with Reduced Ejection Fraction Admitted to Cardiac and Non-Cardiac Units in a Tertiary Hospital Network. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.23.009
Vancouver
Peterson M, Potts C, Ang RJ. Inadvertent Sodium Administration from Medicines, Intravenous Fluid Therapy, and Diluents in Patients with Heart Failure with Reduced Ejection Fraction Admitted to Cardiac and Non-Cardiac Units in a Tertiary Hospital Network. Research in Clinical Pharmacy. 2023. doi:10.59931/rcp.23.009
BibTeX
@article{Peterson2023,
author = {Peterson, Mikah and Potts, Cassandra and Ang, Ru Jing},
title = {Inadvertent Sodium Administration from Medicines, Intravenous Fluid Therapy, and Diluents in Patients with Heart Failure with Reduced Ejection Fraction Admitted to Cardiac and Non-Cardiac Units in a Tertiary Hospital Network},
journal = {Research in Clinical Pharmacy},
year = {2023},
doi = {10.59931/rcp.23.009}
}
EUVIMED